Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 16 Feb 2023
Abbott has previously opposed legislation to test strips, but noted an 89% increase in fentanyl deaths in Texas over the past year.
Read Full NewsKYV-101 shows promising efficacy in treating generalized myasthenia gravis, offering hope for durable remission through innovative CAR T-cell therapy.
Daniel Mikol, MD, PhD, vice president of neuroscience development at AbbVie, discussed how precision tools, AI, and patient partnership are reshaping the design and execution of modern neuroscience clinical trials.
MIL62 Shows Increased Remission and Reduced Relapse Versus Cyclosporine A in MN
AGA Releases Updated Clinical Crohn’s Disease Guideline Reflecting New Therapies
Skin of Color Savvy: A New Podcast Episode Following SOCS Media Day
The HCPFive: Top News for Healthcare Providers from the Week of 11/16
1.
Child Death Rates Are Rising in the U. s. ; Water Beads Warning; Cancer Studies Retracted.
2.
Potentially Novel Approach for Treating Advanced Colorectal Cancer with KRAS Mutations.
3.
For elderly, unfit patients, the all-oral AML regimen shows promise.
4.
No PFS Benefit With Immune Checkpoint Inhibitor Rechallenge in Renal Cell Carcinoma
5.
New analysis helps discern benign from malignant thyroid growths
1.
The Role of Alanine Aminotransferase in Liver Health and Disease
2.
Myeloproliferative Disorders: Causes, Symptoms and Treatment Options
3.
Can Wearables and AI Become a Gamechanger for Histiocytic Cancer Detection?
4.
The Importance of Corrected Calcium Levels in Managing Health Conditions
5.
Multiple Primary Lung Cancer: Multidisciplinary Advances in Diagnosis and Care
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
2.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
4.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
5.
Current Scenario of Cancer- The Incidence of Cancer in Men
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge